Using dexmedetomidine and esketamine for sedation in young children before surgery
Official title: Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia
Run by Second Affiliated Hospital of Wenzhou Medical University · NCT06853431 · Data updated 2026-11-12
This study tests if a combination of two medications, dexmedetomidine and esketamine, can help young children feel calm and relaxed before surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 12 Months to 72 Months |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Second Affiliated Hospital of Wenzhou Medical University Academic / other |
| Locations | 2 sites (Wenzhou, Zhejiang and 1 other locations) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | November 30, 2025 |
| Study ends | November 30, 2025 |
| Registry record updated | December 2, 2025 |
| Trial ID | NCT06853431 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 1 to 6 years who require general anesthesia for elective surgery and have no contraindications for sedation.
✕Probably not a fit
Patients with a history of adverse reactions to sedation or those with significant medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of intranasal dexmedetomidine combined with esketamine for preoperative sedation in pediatric patients undergoing general anesthesia. Children aged 1 to 6 years are randomly assigned to two age groups, and their sedation levels are assessed using the Ramsay Sedation Scale after administering the medications. The study aims to determine the effective doses (ED50 and ED95) of these drugs to improve sedation compliance and reduce adverse postoperative effects. The methodology includes a unique dose adjustment strategy based on the sedation response of previous participants.
Why it matters
Potential benefit: If successful, this approach could enhance sedation effectiveness and safety for young children undergoing surgery.
How similar studies have gone: While the combination of dexmedetomidine and esketamine is being explored, similar studies have shown promise in improving sedation outcomes in pediatric anesthesia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ASA physical status classification Grade I or II; 2. Age 1-6 years old; 3. Children who need to undergo general anesthesia for elective surgery; 4. Weight within the normal range; 5. Signed informed consent form. - Exclusion Criteria: 1. The child's guardian or the child themselves refuses to participate in the study; 2. Patients with contraindications for sedation/anesthesia or a history of abnormal recovery from sedation/anesthesia; 3. Individuals known to be allergic to the study drugs, opioid drugs, or rescue medications; 4. Individuals with a history of heart, brain, liver, kidney, or metabolic diseases; 5. Individuals with an upper respiratory tract infection within the past two weeks; 6. Individuals with other diseases that may cause harm to the subject. -
Where it's running
-
The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China Recruiting -
The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China Not yet recruiting
Study contacts
- Principal investigator: Huacheng Liu — Second Affiliated Hospital of Wenzhou Medical University
- Study coordinator: Huacheng Liu
- Email: huachengliu@163.com
- Phone: 18957755138
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intranasal dexmedetomidine‑esketamine for pain relief after adenoid and tonsil surgery in children
This trial will test whether giving children aged 3–7 a combined dexmedetomidine and esketamine nasal dose reduces pain after adenoid and tonsil surgery.
-
Dexmedetomidine and esketamine given around surgery to improve recovery after general anesthesia
This trial will test whether giving dexmedetomidine, esketamine, or both during the perioperative period helps adults recover better after surgery under general anesthesia.
-
Remimazolam, dexmedetomidine, or esketamine to calm young children before surgery
This trial will test which of three drugs—remimazolam, dexmedetomidine, or esketamine—best calms children aged 2–5 before adenotonsillectomy and reduces postoperative agitation.
-
Combining dexmedetomidine and esketamine to improve sleep after major surgery
This study is testing whether a mix of two medications, dexmedetomidine and esketamine, can help adults sleep better after major surgery compared to a placebo.
-
Using Dexmedetomidine and Esketamine to Reduce Bladder Discomfort from Catheters
This study is testing if the combination of two medications, dexmedetomidine and esketamine, can help reduce bladder discomfort caused by catheters in patients having urological surgery.
-
Esketamine dose levels combined with dexmedetomidine to reduce pain after scoliosis correction
This study will test whether different doses of esketamine given with dexmedetomidine and opioids can reduce immediate postoperative pain and lower the chance of chronic postsurgical pain in adults having scoliosis correction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.